Ignite Creation Date:
2024-05-06 @ 5:05 PM
Last Modification Date:
2024-10-26 @ 2:22 PM
Study NCT ID:
NCT05197712
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-05-24
First Post:
2022-01-15
Brief Title:
Evaluation of the Safety Tolerability and Reactogenicity of the Baiya SARS-CoV-2 Vax 2 Vaccine for COVID-19 Disease
Sponsor:
Baiya Phytopharm Co Ltd
Organization:
Baiya Phytopharm Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-28
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-29
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-04-10
Completion Date Type:
ESTIMATED
First Submit Date:
2022-01-15
First Submit QC Date:
January 15 2022
Study First Post Date:
2022-01-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-23
Last Update Post Date:
2023-05-24
Last Update Post Date Type:
ACTUAL